[go: up one dir, main page]

ME02193B - Derivati imidazola kao inhibitori enzima pde10a - Google Patents

Derivati imidazola kao inhibitori enzima pde10a

Info

Publication number
ME02193B
ME02193B MEP-2015-130A MEP13015A ME02193B ME 02193 B ME02193 B ME 02193B ME P13015 A MEP13015 A ME P13015A ME 02193 B ME02193 B ME 02193B
Authority
ME
Montenegro
Prior art keywords
imidasol
derivatives
enzyme inhibitors
pde10a enzyme
pde10a
Prior art date
Application number
MEP-2015-130A
Other languages
English (en)
Inventor
Mauro Marigo
Morten Langgard
Jan Kehler
Jacob Nielsen
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of ME02193B publication Critical patent/ME02193B/me

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MEP-2015-130A 2010-11-19 2011-11-18 Derivati imidazola kao inhibitori enzima pde10a ME02193B (me)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US41535610P 2010-11-19 2010-11-19
DKPA201001045 2010-11-19
PCT/DK2011/000136 WO2012065612A1 (en) 2010-11-19 2011-11-18 Imidazole derivatives as pde10a enzyme inhibitors
EP11793325.9A EP2640731B9 (en) 2010-11-19 2011-11-18 Imidazole derivatives as pde10a enzyme inhibitors

Publications (1)

Publication Number Publication Date
ME02193B true ME02193B (me) 2016-02-20

Family

ID=45217102

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2015-130A ME02193B (me) 2010-11-19 2011-11-18 Derivati imidazola kao inhibitori enzima pde10a

Country Status (32)

Country Link
EP (1) EP2640731B9 (me)
JP (1) JP5937608B2 (me)
KR (1) KR101916487B1 (me)
CN (1) CN103328487B (me)
AP (1) AP3342A (me)
AR (1) AR083926A1 (me)
AU (1) AU2011331607B2 (me)
BR (1) BR112013012378A2 (me)
CA (1) CA2817663C (me)
CR (1) CR20130226A (me)
DK (1) DK2640731T3 (me)
EA (1) EA027082B1 (me)
EC (1) ECSP13012698A (me)
ES (1) ES2547090T3 (me)
GE (1) GEP20156346B (me)
GT (1) GT201300130A (me)
HU (1) HUE025596T2 (me)
JO (1) JO3089B1 (me)
ME (1) ME02193B (me)
MY (1) MY163327A (me)
NZ (1) NZ610353A (me)
PE (1) PE20141534A1 (me)
PH (1) PH12013500968A1 (me)
PL (1) PL2640731T3 (me)
PT (1) PT2640731E (me)
RS (1) RS54210B1 (me)
SG (1) SG190282A1 (me)
SI (1) SI2640731T1 (me)
TW (1) TWI541245B (me)
UA (1) UA112065C2 (me)
WO (1) WO2012065612A1 (me)
ZA (1) ZA201303607B (me)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8552045B2 (en) 2010-11-19 2013-10-08 H. Lundbeck A/S Tricyclic imidazole compounds as PDE10 inhibitors
ES2627788T3 (es) * 2011-01-11 2017-07-31 Sunovion Pharmaceuticals Inc. Compuestos heteroarilo y procedimientos de uso de los mismos
WO2013045607A1 (en) * 2011-09-30 2013-04-04 H. Lundbeck A/S Quinazoline linked heteroaromatic tricycle derivatives as pde10a enzyme inhibitors
WO2013107856A1 (en) * 2012-01-20 2013-07-25 H. Lundbeck A/S Imidazole derivatives as pde10a enzyme inhibitors
CA2874180A1 (en) 2012-06-19 2013-12-27 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof
CN103435617B (zh) * 2013-08-22 2016-04-27 南京华安药业有限公司 一种6,7-二氢-5H-吡咯并[1,2-a]咪唑-2-甲醛的合成方法
JO3627B1 (ar) 2015-04-30 2020-08-27 H Lundbeck As إيميدازو بيرازينونات على هيئة مثبطات pde1
TWI729109B (zh) 2016-04-12 2021-06-01 丹麥商H 朗德貝克公司 作爲PDE1抑制劑的1,5-二氫-4H-吡唑并[3,4-d]嘧啶-4-酮和1,5-二氫-4H-吡唑并[4,3-c]吡啶-4-酮
EP3529250B1 (en) 2016-10-18 2023-12-06 H. Lundbeck A/S Imidazopyrazinones, pyrazolopyrimidinones and pyrazolopyridinones as pde1 inhibitors
US10912773B2 (en) 2016-10-28 2021-02-09 H. Lundbeck A/S Combinations comprising substituted imidazo[1,5-a]pyrazinones as PDE1 inhibitors
US10905688B2 (en) 2016-10-28 2021-02-02 H. Lundbeck A/S Combinations comprising substituted imidazo[1,5-α]pyrazinones as PDE1 inhibitors
TW202031250A (zh) 2018-11-06 2020-09-01 丹麥商H 朗德貝克公司 用於治療負性症狀和認知損傷之pde10a抑制劑
CN109776527A (zh) * 2019-02-21 2019-05-21 药雅科技(上海)有限公司 一种5-溴-7-氮杂吲哚的合成方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8307865D0 (en) 1983-03-22 1983-04-27 Fujisawa Pharmaceutical Co Benzimidazole derivatives
US5571775A (en) 1994-07-11 1996-11-05 Dowelanco N-aryl[1,2,4]triazolo[1,5-a]pyridine-2-sulfonamide herbicides
IL149106A0 (en) 2001-04-20 2002-11-10 Pfizer Prod Inc Therapeutic use of selective pde10 inhibitors
US20030032579A1 (en) 2001-04-20 2003-02-13 Pfizer Inc. Therapeutic use of selective PDE10 inhibitors
US20070105840A1 (en) 2003-06-30 2007-05-10 Altana Pharma Ag Pyrrolo-dihydroisoquinoline derivatives as pde10 inhibitors
CA2530317A1 (en) 2003-06-30 2005-01-13 Altana Pharma Ag Pyrrolodihydroisoquinolines useful in the treatment of cancer
EP1651251A4 (en) 2003-07-31 2008-06-18 Bayer Pharmaceuticals Corp METHOD FOR THE TREATMENT OF DIABETES AND RELATED DISEASES USING PDE 10A INHIBITORS
WO2005082883A2 (en) 2004-02-18 2005-09-09 Pfizer Products Inc. Tetrahydroisoquinolinyl derivatives of quinazoline and isoquinoline
JP2008501776A (ja) 2004-06-07 2008-01-24 ファイザー・プロダクツ・インク 肥満に関連し、かつメタボリックシンドロームに関連する状態の治療としてのホスホジエステラーゼ10の阻害
US20060019975A1 (en) 2004-07-23 2006-01-26 Pfizer Inc Novel piperidyl derivatives of quinazoline and isoquinoline
AU2005282721A1 (en) 2004-09-03 2006-03-16 Memory Pharmaceuticals Corporation 4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms
UA102693C2 (ru) * 2008-06-20 2013-08-12 Х. Луннбек А/С Производные фенилимидазола как ингибиторы фермента pde10a
TWI501965B (zh) * 2008-06-20 2015-10-01 Lundbeck & Co As H 作為pde10a酵素抑制劑之新穎苯基咪唑衍生物
US8133897B2 (en) 2008-06-20 2012-03-13 H. Lundbeck A/S Phenylimidazole derivatives as PDE10A enzyme inhibitors
TWI485151B (zh) * 2009-12-17 2015-05-21 Lundbeck & Co As H 作為pde10a酵素抑制劑之雜芳香族苯基咪唑衍生物
TWI481607B (zh) * 2009-12-17 2015-04-21 Lundbeck & Co As H 作為pde10a酵素抑制劑的2-芳基咪唑衍生物
TW201200516A (en) * 2009-12-17 2012-01-01 Lundbeck & Co As H Phenylimidazole derivatives comprising an ethynylene linker as PDE10A enzyme inhibitors

Also Published As

Publication number Publication date
AU2011331607A1 (en) 2013-05-30
PT2640731E (pt) 2015-10-13
MY163327A (en) 2017-09-15
RS54210B1 (en) 2015-12-31
CA2817663A1 (en) 2012-05-24
UA112065C2 (uk) 2016-07-25
SG190282A1 (en) 2013-06-28
EA201390741A1 (ru) 2013-11-29
ES2547090T3 (es) 2015-10-01
HUE025596T2 (en) 2016-03-29
AR083926A1 (es) 2013-04-10
EP2640731B9 (en) 2015-11-25
EP2640731B1 (en) 2015-07-08
CN103328487A (zh) 2013-09-25
KR101916487B1 (ko) 2018-11-07
ECSP13012698A (es) 2013-08-30
PL2640731T3 (pl) 2015-11-30
JP2013542963A (ja) 2013-11-28
NZ610353A (en) 2015-01-30
AU2011331607B2 (en) 2016-05-19
JO3089B1 (ar) 2017-03-15
PE20141534A1 (es) 2014-11-16
BR112013012378A2 (pt) 2016-08-30
DK2640731T3 (en) 2015-08-31
EA027082B1 (ru) 2017-06-30
WO2012065612A1 (en) 2012-05-24
PH12013500968A1 (en) 2022-10-24
SI2640731T1 (sl) 2015-10-30
GEP20156346B (en) 2015-08-10
GT201300130A (es) 2015-01-16
CR20130226A (es) 2013-09-03
AP3342A (en) 2015-07-31
CN103328487B (zh) 2015-11-25
TW201300391A (zh) 2013-01-01
CA2817663C (en) 2020-04-28
KR20140009192A (ko) 2014-01-22
EP2640731A1 (en) 2013-09-25
JP5937608B2 (ja) 2016-06-22
TWI541245B (zh) 2016-07-11
ZA201303607B (en) 2014-07-30
AP2013006928A0 (en) 2013-06-30

Similar Documents

Publication Publication Date Title
ME02193B (me) Derivati imidazola kao inhibitori enzima pde10a
SMT201500271B (it) Inibitori di neprilisina
SMT201600108B (it) Derivato di pirazochinolina come inibitori di pde9
SMT201600311B (it) Inibitori di cdk
DK3178818T3 (da) Pyrazolylquinoxalinkinasehæmmere
SMT201600298B (it) Derivati n3-sostituiti-n1-solfonil-5- fluoropirimidinone
SMT201500270B (it) Derivati di pirrolotriazinone come inibitori di pi3k
CO6940421A2 (es) Inhibidores de neprilisina
ZA201305826B (en) Substituted amminobutyric derivatives as neprilysin inhibitors
DK2685986T3 (da) Glucosylceramidsyntasehæmmer
CO6781493A2 (es) Inhibidores de la faah
DK2590974T3 (da) Tetrahydropyridopyrimidinderivater
DK2513105T3 (da) 2-arylimidazolderivater som pde10a-enzyminhibitorer
EP2785183A4 (en) TRIAZOLOPYRIDINONE PDE10 INHIBITORS
BR112013014952A2 (pt) inibidores de neprilisina
CO6990717A2 (es) Derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina
ME02312B (me) DERIVATI PIRAZOLOSPIROKETONA, NAMIJENJENI UPOTREBI KAO INHIBITORI ACETIL-CoA-KARBOKSILAZE
DOP2011000397A (es) Nuevos derivados de fenilimidazol como inhibidores de la enzima pde10a
CO6890101A2 (es) Inhibidores de pde10 de pirimidina
DK2513106T3 (da) Heteroaromatiske aryltriazol-derivater som pde10a-enzyminhibitorer
EP2563127A4 (en) PROLYLCARBOXYPEPTIDASE INHIBITORS
CO6900148A2 (es) Inhibidores de la enzima activadora de nedd8
EP2621276A4 (en) INHIBITORS OF 2-ALCOXY PYRIMIDINE PDE10
EP2613438A4 (en) AMPLIFIER
EP2629616A4 (en) SUBSTITUTED AMINO-TRIAZOLYL-PDE10-HEMMER